ARPO Insider Stats

► Percent Outstanding Insider Ownership

1.15%

► Percent Outstanding Institution Ownership

30.18%

ARPO Social Stats

► Followers

0

► B/S Rating Today

0

► B/S Rating All-Time

N/A

► More Social Data

ARPO in Pulse Portal

► Stream of Posts

ARPO Symbol Page

Share ARPO Insights

► Express Sentiment

'Buy' or 'Sell' ARPO

► Post

Share Your Opinion of ARPO

ARPO Profile

► CEO

Mr. Muneer A. Satter

► Exchange

Nasdaq

► Employees

25.00

► About

Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. Its lead program include a Tie2 activator for diabetic retinopathy and hypoxia-inducible factor. The company was founded by Joseph...

ARPO Financials

Annual Financials

Income Statement

► Revenue

11.54M

► Net Income

292.61%

Cash Flow Statement

► Change in Cash / Investments

18.65M

Balance Sheet

► Cash / Investments

20.26M

► Short Term Debt

None

► Long Term Debt

None

► Total Current Assets

20.9M

► Total Current Liabilities

3.59M

► Total Assets

21.03M

► Total Liabilities

3.59M

► Stockholder Equity

17.44M

Quarterly Financials

Income Statement

► Q Revenue

18.82M

► Q Net Income

11.54M

Cash Flow Statement

► Q Change in Cash / Investments

24,057

Balance Sheet

► Q Cash / Investments

68.81M

► Q Short Term Debt

None

► Q Long Term Debt

None

► Q Total Current Assets

70.04M

► Q Total Current Liabilities

3.64M

► Q Total Assets

70.16M

► Q Total Liabilities

3.64M

► Q Stockholder Equity

66.52M

ARPO Charts

► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

MYGN

► Key Statistics

Cap: 2.466B

P/E: 109.97

P/S: 3.19

Q P/B: 2.33

Y Rev: 772.6M

Q Rev: 216.8M

Beta: 1.15

MYGN Share Stats

► Outstanding Shares

73.27M

► Float Shares

71.43M

► Percent of Float Short

21.25%

MYGN Insider Stats

► Percent Outstanding Insider Ownership

N/A

► Percent Outstanding Institution Ownership

6% per year%

MYGN Social Stats

► Followers

0

► B/S Rating Today

0

► B/S Rating All-Time

N/A

► More Social Data

MYGN in Pulse Portal

► Stream of Posts

MYGN Symbol Page

Share MYGN Insights

► Express Sentiment

'Buy' or 'Sell' MYGN

► Post

Share Your Opinion of MYGN

MYGN Profile

► CEO

Mr. Mark C. Capone

► Exchange

Nasdaq

► Employees

2,400

► About

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through Diagnostics and Other segments. The Diagnostics segment engages in the provision of testing and collaborative development of testing...